“We endorsed Cory Booker during his election campaign in 2013 and we are honored to do so again,” stated NORML PAC manager Erik Altieri, “Senator Booker kept the promises he made to champion crucial criminal justice and marijuana reform issues in his first term. If re-elected for a full six year term this fall, he will be a strong crusader for rolling back our failed war on cannabis at the federal level. We encourage New Jersey voters to support him in his campaign.”
In an previous interview with Huffington Post, Booker laid out his view on marijuana policy and the drug war:
“Medical marijuana, heck yes. I do not understand that there are drugs that are more toxic, more dangerous and more challenging, in drugs stores around my state, yet we single out this one drug and we say you can’t even have it in a medical fashion, at a time when I see prescription drugs from Adderall to you name it being used widely across our nation…
The reason I said I want to go beyond that…is because of the drug war.
We have seen so much of our national treasure being spent in the national drug war and in my opinion have turned human life into incarceration, trapping into poverty…
What I’ve seen in Newark is a massive trap in this drug war, and its not just a trap for the individuals being arrested, it’s a trap for taxpayers, communities and towns. We’re not making our nation safer with this assault on this drug war, we are not making our state less addicted to substances. We need to change, radically change, the conversation and begin to talk about drugs, especially drugs like pot, in a different way.
This is a conversation that no matter what I do, Mayor, Governor, Senator, I want to be one of the people, hopefully, trying to lead the national conversation away from this insanity that we have now.”
During his first year in office, Sen. Booker joined forces with Kentucky Senator Rand Paul to introduce an amendment to an appropriations bill that would have prohibited the federal government from spending taxpayer money to interfere with state medical marijuana laws. The measure ultimately did not come up for a vote, due to political maneuvering unrelated to the marijuana issue, but it marks the first time in recent history the issue was brought up in a positive way in the upper chamber of the US Congress. We fully expect, if re-elected, that Senator Booker will continue to be one of the most prominent and effective champions for federal reform in the Senate.
NORML PAC has endorsed Representative Earl Blumenauer (OR-03) in his campaign to be re-elected to the US House of Representatives.
“Rep. Blumenauer has been a supporter and proponent of marijuana law reform since his days in the Oregon State Legislature decades ago,” stated NORML PAC Manager Erik Altieri, “In Congress, he has introduced and championed bills that would dismantle our federal war on cannabis and we encourage voters in his district to re-elect him for another term so he can keep pursuing these important policy changes.”
As Congressman, in addition to being a primary sponsor or co-sponsor on all federal pro-marijuana law reform measures, Blumenauer published an in-depth report titled “A Path Forward: Rethinking Marijuana Policy” which calls for an end to federal prohibition and advocates for many of the reforms NORML has been fighting for all these years.
Rep. Blumenauer has also been a notable presence at the federal marijuana hearings this year being held by the Committee on Government Oversight. You can watch him call out ONDCP acting director Botticelli below:
One of Rep. Blumenauer’s re-election campaign ads focuses on marijuana law reform and calls for allowing states the freedom to set their own marijuana policies and pursue legalization:
Nearly fifteen years after the release of “Because I Got High”- a song well known for poking fun at overzealous reefer madness rhetoric – Afroman is ready to jump headfirst back into the marijuana limelight. Only this time, as an advocate for legalization.
The grammy nominated artist recently teamed up with NORML and Weedmaps to launch a remake of his hit song, turning the hip hop classic into a positive legalization anthem for the 2014 elections. The remix is a new and entertaining way to drive the narrative surrounding the benefits of cannabis law reform, as well as the medical benefits of the plant itself. With election day right around the corner, his latest project is geared towards keeping up the momentum for all the marijuana law reform efforts taking place across the country, and especially upcoming ballot initiatives.
On November 4th, two states and the District of Columbia will be voting to legalize marijuana, and Florida will be voting on a medical marijuana amendment. The timing couldn’t have been better to take, and remake the canna-cult classic. The 2014 version of “Because I Got High” not only challenges old stereotypes, it also seeks to build support and enthusiasm for the three measures proposing to create a regulated pot market for adults, age 21 and over.
Through digital engagement, this song pushes an important political message to a younger, social media savvy voting block, energizing the demographic known to be the among the biggest supporters of ending marijuana prohibition. From glaucoma to funding school construction, the song highlights many of the social, medical and economic benefits of legalization in a fun and informative way.
“NORML is thrilled to have brought Weedmaps and Afroman together to create this unique cultural collaboration merging art, entertainment, and activism into a single campaign that highlights many of the positive benefits of cannabis, and raises awareness for for the legalization initiatives coming up in the 2014 November elections,” said NORML Director of Strategic Partnerships Sabrina Fendrick.
Check out the video and share with all your like-minded friends. Together, we can #SmokeTheVote!
Israeli investigators intend to evaluate the potential anti-tumoral effects of the canabinoid cannabidiol (CBD) in select cancer patients.
Researchers at the Hassadah Medical Center in Jerusalem will conduct a Phase II clinical trial to assess the impact of CBD as single treatment in cancer patients who have failed to respond to conventional therapies. Participants in the trial will receive CBD therapy for a period of eight weeks.
Data documenting the potent anti-cancer activity of various cannabinoids – including THC, CBD, and CBG – both in culture and in animals dates back to the mid-1970s. To date, however, virtually no clinical trials exist reproducing these results in human subjects.
In August, pharmaceutical provider Insys Therapeutics announced that it had received orphan drug status for its proprietary formulation of CBD for the treatment of glioblastoma, a hard-to-treat, aggressive form of brain cancer.
Organic CBD remains classified under federal law as a schedule I controlled substance.
Further details of the forthcoming Israeli trial are available online from the clinicaltrials.gov website here. Patient recruitment has yet to begin for this study.
In what may be the most difficult ballot initiative to evaluate in advance of the upcoming mid-term elections, the voters in Alaska will decide on November 4 whether to approve full marijuana legalization for all adults, including retail sales.
For most of us, Alaska, the largest state in the Union by area, and the least densely populated, is an exotic location, far removed from the Lower 48 both geographically and culturally. The largest city, Anchorage, has a population of only 292,000, and the second largest, Fairbanks, has only 32,000 residents. The Alaska territory was purchased from Russia in 1867 and only became a state in 1959. The state has always leaned heavily Republican, which might suggest it would be an unlikely state for marijuana legalization to appear on the ballot; but the state is also known as the home of a lot of people who want to minimize the role of government in their lives, which would appear to bode well for legalizers.
History of Marijuana Legalization in Alaska
To read the balance of this article, go to